UNIVERSITE D'AUVERGNE CLERMONT I

Patent Applications and Registrations

Patent applications and USPTO patent grants for UNIVERSITE D'AUVERGNE CLERMONT I.The latest application filed is for "macrocyclic complexes, their process of preparation and use as pet imaging agents".

Company Profile

2.9.10

UNIVERSITE D'AUVERGNE CLERMONT I - Clermont Ferrand N/A FR
Universite d'Auvergne Clermont I - Clermond Ferrand FR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Macrocyclic complexes, their process of preparation and use as PET imaging agents Grant 10,351,539 - Denis , et al. July 16, 2	2019-07-16
Use of microorganisms for reducing the level of trimethylamine in a human body cavity, in particular for the treatment of trimethylaminuria or of bacterial vaginosis and the prevention of cardiovascular diseases Grant 10,238,695 - Brugere , et al.	2019-03-26
Method of calibrating a computer-based vision system onboard a craft Grant 9,728,005 - Dhome , et al. August 8, 2	2017-08-08
Macrocyclic Complexes, Their Process Of Preparation And Use As Pet Imaging Agents App 20170210714 - DENIS; Claire ; et al.	2017-07-27
Use of riluzole for treating or preventing the adverse effects of antineoplastic agents Grant 9,511,045 - Busserolles , et al. December 6, 2	2016-12-06
Use of K2P potassium channel activators as antalgics Grant 9,448,242 - Eschalier , et al. September 20, 2	2016-09-20
Use Of Microorganisms For Reducing The Level Of Trimethylamine In A Human Body Cavity, In Particular For The Treatment Of Trimethylaminuria Or Of Bacterial Vaginosis And The Prevention Of Cardiovascular Diseases App 20160074440 - BRUGERE; Jean-Francois ; et al.	2016-03-17
Pain Relief Compounds App 20150274633 - DUCKI; Sylvie ; et al.	2015-10-01
Labelled Quinoxaline Derivatives as Multimodal Radiopharmaceuticals and Their Precursors App 20150079000 - Chezal; Jean-Michel ; et al.	2015-03-19
Antagonists for the prevention or treatment of inflammatory bowel disease, and more particularly of Crohn's disease Grant 8,974,789 - Darfeuille-Michaud , et al. March 10, 2	2015-03-10
Pain Relief Compounds App 20150038466 - Ducki; Sylvie ; et al.	2015-02-05
Aqueous Lock Composition Comprising Ethanol and a Polysaccharide Anticoagulant App 20140371171 - Souweine; Bertrand	2014-12-18
Anticancer Active Ingredient From Guiera Senegalensis App 20140348958 - Chalard; Pierre ; et al.	2014-11-27
Method Of Calibrating A Computer-based Vision System Onboard A Craft App 20140267608 - Dhome; Michel ; et al.	2014-09-18
Antagonists for the Prevention of Treatment of Inflammatory Bowel Disease, and More Particularly of Crohn's Disease App 20130084292 - Darfeuille-Michaud; Arlette ; et al.	2013-04-04
Use Of Riluzole For Treating Or Preventing The Adverse Effects Of Antineoplastic Agents App 20130064775 - Busserolles; Jerome ; et al.	2013-03-14
Device for simulating a stomach of a monogastric mammal or of a human being Grant 8,257,085 - Alric , et al. September 4, 2	2012-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.